Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

You are here: Home » News & Analysis

News & Analysis

Print

China biotech company and industry news and analysis...

Recent Articles

  China's CFDA Raises Fees for Drug Review
  3SBio Sets Target of $712 Million for Hong Kong IPO
  SciClone Pays $6 Million for China Rights to Theravance's Antibiotic
  Youbo Pharma Acquired by Jiuzhitang in $1 Billion Reverse Takeover
  Cellular Biomedicine Reports Positive China CAR-T Cancer Data
  Ambrx of San Diego Acquired by Fosun Pharma, WuXi PharmaTech and Others
  GenorBio Enlists MabSpace to Discover mAbs
  WuXi PharmaTech Announces eCommerce Research Chemicals Service
  China Medical Systems In-Licenses Respiratory Distress Drug from Faron
  Livzon Pharma to Form China JV with Cynvenio
 
Login

  

    
   
Partner Events

Bio Taiwan 2015
July 22-26, 2015
Taipei, Taiwan

>> More events...
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors